Clinical Trials for Metastatic Pancreatic Ductal Adenocarcinoma

Find clinical trials for metastatic pancreatic ductal adenocarcinoma. Discover research opportunities and treatment options in your area.

20 Active Trials Found

Showing 20 trials on this page

Page 1 of 1

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

NCT ID: NCT06843551

The Miami "EMPIRE" Trial is a clinical study looking at a new treatment approach for patients with metastatic pancreatic cancer, specifically a type called pancreatic ductal adenocarcinoma. The res...

Recruiting

Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

NCT ID: NCT06989437

This clinical trial is studying a new medicine called ponsegromab for adults who have advanced pancreatic cancer that has spread to other parts of the body and is causing significant weight loss an...

Not yet recruiting

Phase: PHASE2 Type: interventional

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

NCT ID: NCT05685602

This clinical trial is studying a new treatment approach for patients with advanced pancreatic cancer that cannot be surgically removed or has spread to other parts of the body. The researchers are...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Bethesda, Maryland, United States +28 more

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

NCT ID: NCT06917079

This clinical trial is testing a new treatment called BBO-11818 for adults with certain types of cancer that have a specific genetic mutation known as KRAS. The trial is looking at the safety of th...

Recruiting

Phase: PHASE1 Type: interventional Locations: Salt Lake City, Utah, United States, Houston, Texas, United States +2 more

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

NCT ID: NCT06626256

This clinical trial is studying a new treatment called STIL101 for injection, designed to help patients with certain types of advanced cancers, including pancreatic, colorectal, renal cell, cervica...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT06608927

This clinical trial is studying a new treatment called quemliclustat combined with chemotherapy to see if it helps patients with metastatic pancreatic ductal adenocarcinoma (PDAC) live longer compa...

Recruiting

Phase: PHASE3 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Rochester, New York, United States +102 more

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT06648434

This clinical trial is exploring a new treatment option for patients with metastatic pancreatic ductal adenocarcinoma, a type of advanced pancreatic cancer. The study is looking at how a drug calle...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

NCT ID: NCT06168812

This clinical trial is studying a medication called glipizide to see if it can help lower high blood sugar levels in people diagnosed with pancreatic cancer. The researchers want to find out if gli...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +5 more

Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT06981806

This clinical trial is studying the safety and tolerability of two treatments, cosibelimab and balixafortide, for patients with metastatic pancreatic ductal adenocarcinoma (PDAC) who have not respo...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

NCT ID: NCT05737615

This clinical trial is studying a new imaging technique that uses a special substance called hu5B1-TCO and a radioactive material known as 64Cu-Tz-SarAr. The goal is to find the safest dose of thes...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

NCT ID: NCT04821284

This clinical trial is studying a new treatment approach for pancreatic cancer that combines standard chemotherapy with a technique called sonoporation. Sonoporation uses ultrasound waves and tiny ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bergen, , Norway, Philadelphia, Pennsylvania, United States

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

NCT ID: NCT06445062

This clinical trial is studying a new type of treatment called RAS(ON) inhibitors for patients with certain types of gastrointestinal cancers, specifically colorectal cancer and pancreatic cancer. ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Philadelphia, Pennsylvania, United States +20 more

Ontegimod and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT06904378

This clinical trial is studying a new treatment approach for patients with advanced pancreatic cancer that cannot be surgically removed. Researchers want to see if a medication called Ontegimod, co...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States

BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT05558982

This clinical trial is studying the effectiveness of two medications, BXCL701 and pembrolizumab, for patients with metastatic pancreatic ductal adenocarcinoma, which is a type of advanced pancreati...

Recruiting

Phase: PHASE2 Type: interventional Locations: Washington, District Of Columbia, United States, Hackensack, New Jersey, United States +1 more

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

NCT ID: NCT04005690

This clinical trial is investigating how well certain medications work for patients with pancreatic cancer, specifically those with advanced or metastatic forms of the disease. The drugs being test...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Portland, Oregon, United States

A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)

NCT ID: NCT05472259

This clinical trial, called NALPAC, is studying two different treatment combinations for patients with advanced pancreatic cancer that has continued to grow after previous treatments. The treatment...

Recruiting

Phase: PHASE2 Type: interventional Locations: Namur, , Belgium, Bonheiden, , Belgium +12 more

AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer

NCT ID: NCT06646055

This clinical trial is studying a new combination treatment for patients with advanced pancreatic cancer, specifically a type called metastatic pancreatic ductal adenocarcinoma. The researchers wan...

Recruiting

Phase: PHASE1 Type: interventional Locations: Wuhan, Hubei, China

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

NCT ID: NCT02600949

This clinical trial is testing a new treatment called a personalized peptide vaccine for patients with advanced pancreatic or colorectal cancer that has spread to other parts of the body. The vacci...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

NCT ID: NCT06600906

This clinical trial is investigating a new type of MRI scan called hyperpolarized carbon-13 pyruvate MRI to see how well it can predict the response of pancreatic cancer to treatment. This research...

Recruiting

Type: observational Locations: San Francisco, California, United States

SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells

NCT ID: NCT04150042

The SHARON clinical trial is studying a new treatment approach for patients with advanced (stage IV) cancer who have specific genetic mutations called BRCA1, BRCA2, or PALB2. This treatment combine...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions